On March 31, 2009, Regeneron Pharmaceuticals (REGN) had a market capitalization of $1.1B, based on 79.5M shares at a price of $13.86.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
March 31 2009 | $13.86 | 701,300 | 79,498,000 | $1,101,842,280.00 |
March 30 2009 | $14.18 | 690,200 | 79,498,000 | $1,127,281,640.00 |
March 27 2009 | $14.38 | 644,300 | 79,498,000 | $1,143,181,240.00 |
March 26 2009 | $15.13 | 827,200 | 79,498,000 | $1,202,804,740.00 |
March 25 2009 | $14.21 | 367,300 | 79,498,000 | $1,129,666,580.00 |
March 24 2009 | $13.77 | 509,500 | 79,498,000 | $1,094,687,460.00 |
March 23 2009 | $14.03 | 699,600 | 79,498,000 | $1,115,356,940.00 |
March 20 2009 | $13.45 | 719,600 | 79,498,000 | $1,069,248,100.00 |
March 19 2009 | $13.68 | 441,900 | 79,498,000 | $1,087,532,640.00 |
March 18 2009 | $14.45 | 388,800 | 79,498,000 | $1,148,746,100.00 |
March 17 2009 | $14.21 | 451,300 | 79,498,000 | $1,129,666,580.00 |
March 16 2009 | $13.44 | 543,500 | 79,498,000 | $1,068,453,120.00 |
March 13 2009 | $14.03 | 506,100 | 79,498,000 | $1,115,356,940.00 |
March 12 2009 | $13.33 | 623,800 | 79,498,000 | $1,059,708,340.00 |
March 11 2009 | $12.05 | 553,000 | 79,498,000 | $957,950,900.00 |
March 10 2009 | $12.60 | 518,300 | 79,498,000 | $1,001,674,800.00 |
March 09 2009 | $12.40 | 475,000 | 79,498,000 | $985,775,200.00 |
March 06 2009 | $12.67 | 466,200 | 79,498,000 | $1,007,239,660.00 |
March 05 2009 | $12.78 | 717,900 | 79,498,000 | $1,015,984,440.00 |
March 04 2009 | $13.96 | 562,500 | 79,498,000 | $1,109,792,080.00 |
March 03 2009 | $13.81 | 697,800 | 79,498,000 | $1,097,867,380.00 |
March 02 2009 | $13.54 | 898,300 | 79,498,000 | $1,076,402,920.00 |
